Apr 18, 2025 04:14PM

Jun 8, 2023 01:26PM

Mar 22, 2023 04:15PM

Mar 22, 2023 04:15PM

Mar 20, 2023 08:00AM

Mar 20, 2023 08:00AM

Mar 20, 2023 08:00AM Esperion Announces $56.7 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Apr 15, 2022 06:33AM

Dec 3, 2021 05:23AM

Dec 2, 2021 11:40PM

Dec 2, 2021 11:40PM

Dec 2, 2021 05:00PM

Dec 2, 2021 05:00PM

Nov 12, 2021 07:10AM Esperion Therapeutics (ESPR) Presents Important New Science Highlighting Potential Benefits of NEXLETOL Tablets at AHA

Aug 3, 2021 11:06AM

Aug 3, 2021 09:27AM

Mar 18, 2020 07:37AM

Jan 3, 2020 04:28PM

Jan 3, 2020 04:28PM

May 23, 2018 08:15AM

Nov 6, 2017 04:44PM Esperion Therapeutics (ESPR) Commences Pivotal Phase 3 Study for the Bempedoic Acid / Ezetimibe Combination Pill

Oct 2, 2017 04:32PM

Aug 10, 2017 05:53AM

Aug 9, 2017 09:20PM

Aug 8, 2017 04:32PM

Aug 8, 2017 04:32PM

Jun 26, 2017 04:06PM

Mar 21, 2017 09:27AM Pre-Open Movers 03/21: (PTIE) (HTBX) (ESPR) Higher; (CALA) (OCUL) (GEL) Lower (more...)

Dec 22, 2015 04:57PM

May 21, 2015 03:22PM

Mar 24, 2015 04:05PM

Mar 18, 2015 08:15PM

Mar 17, 2015 05:28PM

Dec 22, 2014 04:43PM

68,144 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All